The financial unraveling of Jon Venetos’ Lurin Capital is now the subject of a Federal Bureau of Investigation probe.

At the close on September 14, 2026, GSK stock gained 4.63% in London to 1,854.5 pence, outperforming the FTSE 100 as positive lung cancer trial data drove a session range between roughly 1,770 and ...

KEY fell 4.52% to $20.72 from $21.70 the previous trading day Weiss Ratings assigns B (Buy) Market cap is $23.40B with a ...

Global bond yields retreated Thursday, calming a pressured market after the Federal Reserve’s rate hike and Chairman Kevin Warsh’s vow to tame inflation, while traders awaited Friday’s Bank of Japan ...

Oracle shares have fallen more than 14% in the last five trading sessions. Investors are weighing Oracle’s exposure to OpenAI ...

Meta shares rose as Muse coverage and MTIA 450 chip plans kept Wall Street focused on AI products, compute costs, safety, and analyst ratings today in trading.

A number of stocks fell in the afternoon session after the Federal Reserve delivered its first rate hike in more than three years and Chair Kevin Warsh stressed that inflation risks remain elevated.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Morgan Stanley analysts led by Sanjit Singh pointed to pressure on Oracle’s gross margin and the relatively modest increase in its fiscal 2027 earnings guidance. The analysts said investors would want ...

KeyCorp ( (KEY)) just unveiled an update. KeyCorp reviewed its performance, strategy, and outlook at the Barclays Global Financial Services Conference held on September 14, 2026. The company presented ...

In a report released today, Jason Goldberg from Barclays maintained a Hold rating on KeyCorp, with a price target of $24.00. According to TipRanks, Goldberg is a 5-star analyst with an average return ...

According to MarketBeat on September 14, 2026, KeyCorp kept a Strong-Buy rating on Linde and expects Q3 2026 EPS of USD 4.50, ...